Medios AG
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on onco…
Medical - Distribution
DE, Berlin [HQ]
MEDOF/Financial Reporting
Income Statements
5 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue | 580.00 | 766.00 | 1,542.00 | 1,723.00 | 1,969.00 | |
|
EPS
|
0.75 | 0.44 | 0.42 | 0.83 | 0.87 | |
| Diluted in mil. | 0.73 | 0.42 | 0.42 | 0.82 | 0.87 | |
|
Profit
|
22.00 | 22.00 | 30.00 | 54.00 | 57.00 | |
| Gross Margin | 3.96 | 2.99 | 1.99 | 3.16 | 2.91 | |
| Pre Tax | 15.00 | 10.00 | 15.00 | 29.00 | 32.00 | |
| Profit Margin | 2.75 | 1.42 | 1.00 | 1.73 | 1.65 | |
| ETR | 31.37 | 37.93 | 45.48 | 34.12 | 35.95 | |
| Net | 10.00 | 5.00 | 7.00 | 18.00 | 18.00 | |
| Profit Margin | 1.89 | 0.72 | 0.48 | 1.06 | 0.95 | |
| EBITDA | 17.00 | 15.00 | 37.00 | 52.00 | 55.00 | |
| EBITDA Margin | 3.06 | 2.01 | 2.43 | 3.05 | 2.80 | |
| Operating Income | 15.00 | 11.00 | 15.00 | 28.00 | 31.00 | |
| Operating Margin | 2.67 | 1.45 | 1.01 | 1.67 | 1.62 | |
| Interest Income | - - | - - | - - | - - | - - | |
| Loss | -564.00 | -755.00 | -1,527.00 | -1,695.00 | -1,937.00 | |
| Cost of Revenue | -557.00 | -743.00 | -1,512.00 | -1,669.00 | -1,912.00 | |
|
Operating Expenses
|
-7.00 | -11.00 | -15.00 | -25.00 | -25.00 | |
| R&D | - - | - - | - - | - - | - - | |
| G&A | - - | -3.00 | -2.00 | -4.00 | -6.00 | |
| SG&A | -7.00 | -11.00 | -15.00 | -25.00 | -25.00 | |
| S&M | - - | - - | -1.00 | -1.00 | -1.00 | |
| Depreciation and Amortization | -2.00 | -4.00 | -22.00 | -23.00 | -23.00 | |
| Interest Expenses | - - | - - | -1.00 | -1.00 | -2.00 | |
| Other Expenses | - - | - - | - - | -1.00 | - - | |
|
WA Shares Outstanding
|
14.00 | 15.00 | 20.00 | 23.00 | 23.00 | |
| Diluted | 14.00 | 16.00 | 20.00 | 23.00 | 23.00 |